Zynex Inc - Ordinary Shares
News
Zynex CEO reflects on 28 years of medical device innovation - ICYMI
Proactive Investors - UK Zynex CEO reflects on 28 years of medical device innovation - ICYMI...\n more…
Zynex Inc. CEO Highlights growth and Innovation in Pain Management and Hospital Monitoring
Proactive Investors - UK Zynex Inc. CEO Highlights growth and Innovation in Pain Management and Hospital Monitoring...\n more…
Zynex (NASDAQ:ZYXI) Given "Buy" Rating at HC Wainwright
Ticker Report HC Wainwright restated their buy rating on shares of Zynex (NASDAQ:ZYXI - Free Report) in a report published on Wednesday morning, Benzinga reports. The firm currently has a $16.00 price objective on...\n more…
Zynex Gains FDA Clearance for New TensWave Device, Expands Pain Management Solutions
Proactive Investors - UK Zynex Gains FDA Clearance for New TensWave Device, Expands Pain Management Solutions...\n more…
Zynex to Present at the HC Wainwright Global Investment Conference
PR Newswire Zynex to Present at the HC Wainwright Global Investment Conference Zynex to Present at the HC Wainwright Global Investment Conference PR Newswire ENGLEWOOD, Colo., Sept. 4, 2024 ENGLEWOOD, Colo...\n more…
Zynex pain management device TensWave achieves FDA clearance
Proactive Investors - UK Zynex pain management device TensWave achieves FDA clearance...\n more…